Literature DB >> 3329735

Quality of life in psychosomatic research. A psychometric model.

P Bech1.   

Abstract

The concept of 'quality of life' has had a paradigmatic effect in psychosomatic medicine by focussing on the measurements of psychological distress. This concept has been phenomenologically described under such names as discomfort and psychological boredom. Elements of fatigue, anxiety and depression seem to be core symptoms of dysfunctions in quality of life. An objective and nomothetic approach to quality of life has been demonstrated in this review when referring to the instrumental use of rating scales, e.g. the General Health Questionnaire. Furthermore, it has been recommended to follow the multiaxial approach of DSM-III including dimensions of personality, psychosocial stressors and social functioning.

Entities:  

Mesh:

Year:  1987        PMID: 3329735     DOI: 10.1159/000284496

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  4 in total

1.  Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales.

Authors:  M Albus; W Maier; D Shera; P Bech
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1990       Impact factor: 5.270

Review 2.  Quality-of-Life measurements for patients taking which drugs? The clinical PCASEE perspective.

Authors:  P Bech
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

3.  Psychological distress in pregnancy and preterm delivery.

Authors:  M Hedegaard; T B Henriksen; S Sabroe; N J Secher
Journal:  BMJ       Date:  1993-07-24

4.  Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study.

Authors:  Jessie N Zurita-Cruz; Leticia Manuel-Apolinar; María Luisa Arellano-Flores; Alejandro Gutierrez-Gonzalez; Alma Gloria Najera-Ahumada; Nelly Cisneros-González
Journal:  Health Qual Life Outcomes       Date:  2018-05-15       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.